Addressing Opioids and Stimulants for People with HIV: PSSNY AlbanyMed Conference
At the completion of the activity viewers will be able to:
Describe opioid use disorder
List treatment for opioid use disorders
Describe the implications of opioid use disorders in people living with HIV infection
Describe current options for addressing stimulant use
R. Douglas Bruce, MD, MA, MS
- Dr. Bruce has worked to develop and implement research and public health interventions both locally and internationally. From drug-drug interaction work to ascertain the impact of HIV and HCV therapeutics on methadone/buprenorphine and operations research to improve HIV/HCV and tuberculosis care, he has translated research into clinical environments to improve outcomes for marginalized populations and to reduce health disparities. Dr. Bruce supported the launch of the first public methadone program in Sub-Sahara Africa in Dar es Salaam, Tanzania. Dr. Bruce has provided technical assistance to the CDC (Kenya, Tanzania, and India), the United Nations (Mauritius, Kenya, and Seychelles), USAID (Ukraine), and non-governmental organizations to address HIV and substance use epidemics globally. Dr. Bruce has held academic appointments at Yale School of Medicine, Yale School of Public Health, Boston University School of Medicine, and Case Western Reserve.
ACPE UAN #
- 1.00 ACPEThe Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.